Skip to main content
AVA 2025 Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Separate Fee
Requires Separate Fee
Peds/Neo SIG
Peds/Neo SIG
Patient Track
Patient Track
International Speakers
International Speakers
Scientific Poster Presentations
Scientific Poster Presentations
ACCME Credit
ACCME Credit
CRNI Credit
CRNI Credit
On-Demand
On-Demand
Coffee Break
Coffee Break
Reception
Reception
Meal
Meal
Evaluation On-Demand Video ViewAttendees 41

Abstract Submission

Thrombosis

(K3) Thrombus - Size really doesn't matter: what you need to know!

Sunday, September 21, 2025
8:15 AM - 8:45 AM ET
Location: Desoto 3-4
Earn .5 CE Hour(s)
International Speakers On-Demand
Disclosure(s):
Jocelyn Hill, MN, RN, VA-BC, CVAA(c): Nipro CANADA: Consultant (Terminated, March 1, 2025), Speaker and honourarium received (Terminated, March 1, 2025); Spectrum Vascular: Consultant (Ongoing)
Michael May, RN, VA-BC: Spectrum Vascular: Consultant (Ongoing)
Thrombus, in the realm of vascular access and infusion therapy, is a unique and interesting natural phenomena that occurs physiologically and are related to CVADs. We not only need to fully understand what a thrombus is in general, but also how it occurs and what are the root causes of its formation.
Thrombus formation regardless of it being occlusive or nonocclusive, may or may not obvious, and can be a serious complication and as such, can be preventable.
We will define and explain thrombus from its development to strategies for prevention and treatment. Case studies and patient examples will be used to facilitate the discussion and review.
The use of case studies and patient examples will allow for reflection and understanding gaps in care.
Care for the patient and the CVAD (for insertion and care and maintenance) is important and should be based on best practice standards and using the best strategies and technology available. Understanding thrombus as a hallmark complication that can be the root of other complications, will help clinicians provide best practice and ensure patients receive optimal care when they have a CVAD for any, and all therapies.

Learning Objectives:

  • 1. Provide comprehensive review of thrombus: definition, how it develops, what causes it, contributing factors, and physiology.
  • 2. Discuss CVAD-related thrombus and what happens after thrombus occurs, what is the actual IMPACT and what does it mean?
  • 3. Understand what is out there as strategies and technology for CVADs to deal with thrombus.
  • 4. Discuss new and relevant published evidence on CVAD technology in relation to catheter material and link how this can affect patient care and therapy.